Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
activin, AMR, anaemia, anticoagulant, appraising, array, asthenia, BaFin, Bahnhofstrasse, BidCo, Biegi, biomolecular, bleeding, Boerse, Broadway, bromodomain, burn, CERT, championed, condensed, conditionally, consummate, consummated, consummation, counteract, deadly, delisted, delisting, density, deregistration, dire, DPLTA, Dutch, Dynamic, element, Elm, erroneously, escrow, evolution, excitement, fiber, finanical, FISG, float, Fourteen, Gordon, Gynecologic, Haven, headache, headcount, Homolog, hotspot, IIT, imminent, IMP, impractical, incorrectly, IOC, ISIN, Kirchensteuer, Kynam, landmark, legacy, LP, lump, maplirpacept, mirror, monetization, monetize, monjuvi®, morale, MTD, NIST, NJ, nov, numerical, numerically, obesity, obsolescence, ODD, official, offsett, oversupply, overwhelming, Panmure, peak, pendency, Pillar, pilot, pLoT, PMN, popular, pre, Princeton, prudent, PTCL, questionnaire, recurrent, recycling, redefine, resilient, riskier, runway, sake, scrapping, sentiment, Seoul, sharpened, showcase, showcased, slightly, standalone, Stanley, Steueranmeldung, stratification, stroke, surprisingly, tableting, tactical, tafasistamab, Tim, uncapped, underscoring, ushered, vera, Visit, volunteer, Woodford, worse, Zeste, Zweigniederlassung
Removed:
acute, ADCC, ADCP, age, aggressive, Alzheimer, Amsterdam, amyloid, antigen, antirheumatic, ATAD, atopic, axicabtagene, Baltimore, Basel, bayer, bi, Bochum, boehringer, brentuximab, Breyanzi, Castresana, chemotherapy, chimeric, CHOP, cognitive, commerce, compelling, Conceptual, constitutional, consumed, corticosteroid, Council, curative, cyclophosphamide, cytolytic, cytotoxicity, database, deemphasize, dementia, detected, DHAP, differentiated, diverse, doxorubicin, Dupilumab, emerge, Euronext, Fc, feasible, febrile, Fibron, figure, Finanzgericht, forfeiture, freely, Freie, gained, gantenerumab, GeneFrontier, generating, genetically, Genzyme, geographic, GlaxoSmithKline, grow, habilitated, Hamburg, Hanover, heightening, histone, Historically, homogeneously, ibrutinib, ICE, iloleucel, incl, ingelheim, instrumental, interposition, interrupting, Investmentsteuergesetz, Italy, Johnson, Kapitalbeteiligung, killer, killing, Kymriah, landscape, lengthier, LEO, lisocabtagene, lymphoblastic, Lyon, MA, Mainz, maraleucel, Maria, marketable, Maryland, matched, mdor, Merck, methotrexate, Micromet, mild, moderate, MSD, naked, observational, older, oncomed, OSCAR, Padova, para, parsaclisib, Pasteur, perpetual, phased, pixantrone, PK, plenum, polatuzumab, Polivy, Pratt, prednisone, ProChon, productivity, pulmonary, RA, reexamination, relapse, reliant, remission, restricting, resume, retrospective, rheumatoid, Rheumatology, Rowe, salvage, Sandoz, selection, ship, slower, Sosei, Spain, staffing, stepped, stipulating, suited, Tango, tisagenlecleucel, Toronto, trained, transformative, unconstitutional, uncured, unrelated, unscheduled, vedotin, vincristine, Wendy, Yescarta
Filing tables
Filing exhibits
MPSYF similar filings
Filing view
External links
Exhibit 15.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (Nos. 333-226422, 333-227692, 333-230869, 333-234511, 333-260520 and 333-265727) and Form F-3 (No. 333-275586) of MorphoSys AG of our report dated March 12, 2024 relating to the financial statements and the effectiveness of internal control over financial reporting, which appears in this Form 20-F.
Munich, Germany
March 13, 2024
PricewaterhouseCoopers GmbH
Wirtschaftsprüfungsgesellschaft
/s/ Susanne Riedel /s/ Sebastian Stroner
Wirtschaftsprüferin Wirtschaftsprüfer
(German Public Auditor) (German Public Auditor)